Center for Genetic Engineering and Biotechnology (CIGB). Photo: Pinterest. The Center for Genetic Engineering and Biotechnology (CIGB) announced this Monday in Havana that the Cuban Abdala vaccine candidate has an efficacy of 92.28% with a scheme of three applied doses, according to the clinical studies of the immunogen. With Read more
The Finlay Vaccine Institute (IFV) of Havana will initiate a clinical trial of the Soberana 02 and Soberana Plus vaccine candidates in the pediatric population. The trial will begin with a group of minors from 12 to 18 years old, and will later be extended to the group from 3 to 11 Read more
The Center for the State Control of Medicines, Equipment and Medical Devices (CECMED) announced last Thursday the approval of the Phase III Clinical Trial of the Abdala vaccine candidate, one of the five possible Cuban vaccines against the SARS-CoV-2 virus and the second to begin this phase, the Agencia Cubana de Noticias news Read more
The third phase of clinical trials of the Soberana 02 COVID-19 vaccine will start in Havana next month, executives of the Finlay Vaccine Institute (IFV) confirmed this Wednesday at a meeting of the Provincial Defense Council of the Cuban capital. The director general of the IFV, Dr. Vicente Vérez, affirmed that this Cuban vaccine Read more
Cuba began a new clinical trial aimed at curing the COVID-19 disease, produced by the SARS-CoV-2 virus, which to date has caused more than 40 million infections in the world. This new “vaccine candidate” was registered by the Finlay Vaccine Institute under the name of SOBERANA 01A, which today will start Read more
With the support of Cuban specialists, the Venezuelan health authorities inaugurated this Saturday a new molecular biology laboratory that will allow analyzing around a thousand daily tests to detect the SARS-CoV-2 virus, a crucial contribution amid the rise in positive cases in the South American nation. With almost 10,000 active Read more
Cuba kicks off clinical trials next week of a potential coronavirus vaccine called “Soberana 01” (“Sovereign 01”) developed by its state-run Finlay Institute, with results due in February, state-run media said on Wednesday. The potential coronovirus vaccine will be delivered in two injections during the trials that will involve 676 Read more
Production of the Russian COVID-19 vaccine could begin in Cuba in November, said Kirill Dmitriev, head of the Russian Direct Investment Fund. “Cuba has excellent capabilities to manufacture vaccines. We are discussing the launch of the production with several Cuban enterprises, we believe that Cuba can become one of the Read more
The balance of Covid-19 has been four new infections in the last twenty-four hours in Cuba, a day in which the health authorities registered not only the lowest number of infections since March; instead, according to Dr. Francisco Durán, it is possibly the lowest income: only 296 patients were in hospitals. Read more
The biotechnology sector has been fundamental in Cuba’s successful battle against COVID-19. Thanks to a more than 30-year-old structured and recognized industry, the talent and dedication of its scientists, and the results obtained over decades, the island’s biotechnology has been able to quickly make available to hospitals a battery of products, Read more
Copyright © 2024 | WordPress Theme by MH Themes
